TrialPanorama/TrialPanorama-database huggingface dataset:
Study 10097932 — Surrogate Endpoint (SUR): Blood pressure
Study 10097932 — Surrogate Endpoint (SUR): Serum creatinine
Study 6763455 — Surrogate Endpoint (SUR): Blood pressure
Study 11193245 — Surrogate Endpoint (SUR): Bone mineral density
Study 30196448 — Predictive Biomarker (PRD): SLC4A7 mRNA
Genes: SLC4A7; BT; NBC2; NBC2B; NBC3; NBCn1; SBC2; SLC4A6
Study 22369484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 19660388 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 12353632 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12353632 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16755104 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16755104 — Predictive Biomarker (PRD): Hormone receptor
Study 14747190 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 14747190 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28969404 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 18418314 — Surrogate Endpoint (SUR): Blood pressure
Study 17165278 — Surrogate Endpoint (SUR): Forced vital capacity
Study 17459550 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 17459550 — Safety Biomarker (SAF): BDNF
Study 28252875 — Safety Biomarker (SAF): Interleukin 12
Study 23144450 — Surrogate Endpoint (SUR): Serum uric acid
Study 21448308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21448308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31386821 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31386821 — Safety Biomarker (SAF): BDNF
Study 16458337 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8639444 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 1451052 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 29952519 — Surrogate Endpoint (SUR): Blood pressure
Study 12761365 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12761365 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12761365 — Surrogate Endpoint (SUR): Blood pressure
Study 21601366 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 15155717 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 29402370 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 29402370 — Monitoring Biomarker (MOI): Procalcitonin
Study 29402370 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24914476 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24914476 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 30849015 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 25640830 — Predictive Biomarker (PRD): DRD4 mRNA
Genes: DRD4
Study 17181890 — Surrogate Endpoint (SUR): Bone mineral density
Study 10813102 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10813102 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 10813102 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8785183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7091039 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22092038 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22092038 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 22092038 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22092038 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 22092038 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 22092038 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 18784373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18784373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1317687 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1317687 — Surrogate Endpoint (SUR): Blood pressure
Study 6485438 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 6485438 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 23104956 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 23104956 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 23104956 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 7875277 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 10489079 — Surrogate Endpoint (SUR): Blood pressure
Study 31048579 — Predictive Biomarker (PRD): Microsatellite instability
Study 20816042 — Predictive Biomarker (PRD): USH1G mRNA
Genes: USH1G; SANS
Study 17432112 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 17432112 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 17432112 — Predictive Biomarker (PRD): SMG1 mRNA
Genes: SMG1; ATX; KIAA0421; LIP
Study 17668878 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17668878 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10682570 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 10682570 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 30830727 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25336333 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 9062414 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 28985142 — Safety Biomarker (SAF): Reactive oxygen species
Study 22370318 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22370318 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 22370318 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22370318 — Predictive Biomarker (PRD); Safety Biomarker (SAF): EGFR
Genes: ERBB1; ERRP
Study 18834368 — Surrogate Endpoint (SUR): Blood pressure
Study 6448025 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15537905 — Safety Biomarker (SAF): Interleukin 12
Study 15537905 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 15537905 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15161787 — Surrogate Endpoint (SUR): Blood pressure
Study 15161787 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15161787 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9768439 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 10877171 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8414860 — Surrogate Endpoint (SUR): Blood pressure
Study 17630038 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 17630038 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17630038 — Surrogate Endpoint (SUR): Blood pressure
Study 2939868 — Surrogate Endpoint (SUR): Blood pressure
Study 1447392 — Surrogate Endpoint (SUR): Probing pocket depth
Study 4042549 — Surrogate Endpoint (SUR): Blood pressure
Study 24595047 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16368305 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 16368305 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16368305 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 16368305 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 16368305 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 16368305 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 27799159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15604515 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study 15604515 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 11850305 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10817086 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11398514 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 3318375 — Surrogate Endpoint (SUR): Blood pressure
Study 16325044 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 7047190 — Surrogate Endpoint (SUR): Forced vital capacity
Study 18395477 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 18395477 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 8661952 — Surrogate Endpoint (SUR): Bone mineral density
Study 8661952 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 30715168 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30715168 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 21118176 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12687748 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 30899948 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 24585721 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 24585721 — Surrogate Endpoint (SUR): Pathological complete response
Study 15562085 — Surrogate Endpoint (SUR): Blood pressure
Study 7799411 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 31142636 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31142636 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 16705847 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 8206677 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8206677 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8206677 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 26342236 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 26342236 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 26342236 — Predictive Biomarker (PRD): Hormone receptor
Study 24292815 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 15219644 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 11705814 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 11705814 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 11705814 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 11705814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12612296 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 12612296 — Surrogate Endpoint (SUR): Blood pressure
Study 12612296 — Surrogate Endpoint (SUR): Serum potassium
Study 21194775 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 7508055 — Surrogate Endpoint (SUR): Blood pressure
Study 18647093 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18647093 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 18647093 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 14559692 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 14559692 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23078527 — Predictive Biomarker (PRD): TACR1 mRNA
Genes: TACR1; NK1R; TAC1R
Study 21705063 — Surrogate Endpoint (SUR): Blood pressure
Study 12767550 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12767550 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 23359781 — Surrogate Endpoint (SUR): Serum creatinine
Study 22092271 — Surrogate Endpoint (SUR): Blood pressure
Study 10218040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 19994693 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 9812566 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 29405540 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 18195071 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18195071 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 12766100 — Surrogate Endpoint (SUR): Blood pressure
Study 1909607 — Predictive Biomarker (PRD): ENOSF1 mRNA
Genes: ENOSF1; RTS; TYMSAS
Study 31573928 — Surrogate Endpoint (SUR): Blood pressure
Study 24798080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24798080 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24798080 — Surrogate Endpoint (SUR): Blood pressure
Study 21917733 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16973667 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16973667 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1070142 — Surrogate Endpoint (SUR): Serum creatinine
Study 26493786 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 23540599 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 23540599 — Surrogate Endpoint (SUR): Blood pressure
Study 25392635 — Surrogate Endpoint (SUR): Blood pressure
Study 11870180 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 11161392 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 7957488 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 30584220 — Surrogate Endpoint (SUR): Serum triglycerides
Study 25452097 — Surrogate Endpoint (SUR): Blood pressure
Study 11815511 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 11815511 — Surrogate Endpoint (SUR): Blood pressure
Study 7749804 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 2331203 — Surrogate Endpoint (SUR): Blood pressure
Study 31430404 — Predictive Biomarker (PRD): PNPLA2 mRNA
Genes: PNPLA2; ATGL; FP17548
Study 31430404 — Predictive Biomarker (PRD): G0S2 mRNA
Genes: G0S2
Study 28174194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15184734 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26512046 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study 16564942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 12629463 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 1733001 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11040233 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30184035 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 27812501 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 20200268 — Safety Biomarker (SAF): Urinary microalbumin
Study 20200268 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 2523647 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2523647 — Surrogate Endpoint (SUR): Blood pressure
Study 25102198 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 30735328 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study 30735328 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 30735328 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 26724987 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 24485296 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24485296 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study 31687839 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 31687839 — Predictive Biomarker (PRD): DAZ1 mRNA
Genes: DAZ1; DAZ; SPGY
Study 31687839 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study 27989639 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 12700625 — Surrogate Endpoint (SUR): Blood pressure
Study 26385950 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17327141 — Predictive Biomarker (PRD): LIPC mRNA
Genes: LIPC; HTGL
Study 17327141 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 21609974 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 15997246 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study 30889044 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27502326 — Surrogate Endpoint (SUR): Blood pressure
Study 24939043 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24939043 — Surrogate Endpoint (SUR): Blood pressure
Study 24939043 — Surrogate Endpoint (SUR): Serum creatinine
Study 26357703 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 26357703 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 2996332 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2996332 — Surrogate Endpoint (SUR): Blood pressure
Study 22749221 — Safety Biomarker (SAF): Hyaluronic acid
Study 19835829 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 30420171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24636673 — Surrogate Endpoint (SUR): Blood pressure
Study 22248661 — Surrogate Endpoint (SUR): Serum creatinine
Study 17642235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15080023 — Surrogate Endpoint (SUR): Blood pressure
Study 27718262 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 17317393 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17317393 — Surrogate Endpoint (SUR): Blood pressure
Study 11391126 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 24809448 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study 19020325 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12052589 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 1637600 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 6207648 — Surrogate Endpoint (SUR): Serum uric acid
Study 29913374 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 18806012 — Surrogate Endpoint (SUR): Blood pressure
Study 12706743 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 20720438 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20720438 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 17503745 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17503745 — Surrogate Endpoint (SUR): Serum creatinine
Study 15214256 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15214256 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 12479506 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 10731737 — Surrogate Endpoint (SUR): Blood pressure
Study 11860727 — Surrogate Endpoint (SUR): Bone mineral density
Study 27291761 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 27291761 — Surrogate Endpoint (SUR): Blood pressure
Study 18550965 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 8916982 — Surrogate Endpoint (SUR): Bone mineral density
Study 30588619 — Predictive Biomarker (PRD): Hormone receptor
Study 2571590 — Surrogate Endpoint (SUR): Blood pressure
Study 25671683 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 22095631 — Surrogate Endpoint (SUR): Bone mineral density
Study 12653813 — Surrogate Endpoint (SUR): Blood pressure
Study 10697301 — Surrogate Endpoint (SUR): Blood pressure
Study 29310115 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study 22551017 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 10392221 — Surrogate Endpoint (SUR): Blood pressure
Study 29602570 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 24777708 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 20626054 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 17517341 — Surrogate Endpoint (SUR): Blood pressure
Study 6117261 — Surrogate Endpoint (SUR): Blood pressure
Study 12421024 — Surrogate Endpoint (SUR): Blood pressure
Study 9467537 — Surrogate Endpoint (SUR): Blood pressure
Study 8008792 — Surrogate Endpoint (SUR): Blood pressure
Study 31373701 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19635302 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 27987397 — Monitoring Biomarker (MOI): Procalcitonin
Study 27987397 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25174952 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 20958143 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1